文献速递产科母胎医学

澳大利亚血管前置的诊断、临床实践与结局

Vasa Previa Diagnosis, Clinical Practice, and Outcomes in Australia.
PubMed 文献 · Obstet Gynecol · 2017-01-01

该前瞻性人群队列研究利用澳大利亚产科结局监测系统,于2013年5月1日至2014年4月30日在年分娩量超过50例的医院纳入确诊血管前置孕妇,估算发病率为每1万例分娩2.1例(95%CI 1.7-2.7),产前诊断者均行剖宫产且无围产儿死亡,未产前诊断者围产儿病死率为40%。

要点

  • 澳大利亚血管前置估计发病率为每1万例分娩2.1例(95%CI 1.7-2.7)。
  • 58例产前诊断者全部剖宫产,55例(95%)至少有一项危险因素。
  • 未产前诊断的5例中发生2例围产儿死亡,病死率40%。

核心结论

  • 未产前诊断血管前置的新生儿结局较差,围产儿发病率和死亡率较高;澳大利亚产前诊断率较高且结局良好。

研究设计与样本

  • 前瞻性人群队列研究,使用澳大利亚产科结局监测系统,于2013年5月1日至2014年4月30日在年分娩量超过50例的澳大利亚医院纳入孕期或分娩时经临床检查或胎盘病理确诊的血管前置孕妇。

主要发现

  • 63例确诊血管前置,估计发病率为每1万例分娩2.1例(95%CI 1.7-2.7)。
  • 58例产前诊断者全部剖宫产,其中55例(95%)至少有一项危险因素,最常见为帆状脐带附着(62%)和低置胎盘(60%)。
  • 产前诊断者无围产儿死亡;未产前诊断的5例中发生2例围产儿死亡,病死率40%,其中1例产前死胎经阴道分娩,另4例因胎儿生命紧急威胁行剖宫产,其中1例新生儿死亡。
  • 总围产儿病死率为3.1%(95%CI 0.8-10.5)。
  • 65例新生儿中68%为早产,29%为低出生体重。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the incidence of women with vasa previa in Australia and to describe risk factors, timing of diagnosis, clinical practice, and perinatal outcomes. METHODS: A prospective population-based cohort study was undertaken using the Australasian Maternity Outcomes Surveillance System between May 1, 2013, and April 30, 2014, in hospitals in Australia with greater than 50 births per year. Women were included if they were diagnosed with vasa previa during pregnancy or childbirth, confirmed by clinical examination or placental pathology. The main outcome measures included stillbirth, neonatal death, cesarean delivery, and preterm birth. RESULTS: Sixty-three women had a confirmed diagnosis of vasa previa. The estimated incidence was 2.1 per 10,000 women giving birth (95% CI 1.7-2.7). Fifty-eight women were diagnosed prenatally and all had a cesarean delivery. Fifty-five (95%) of the 58 women had at least one risk factor for vasa previa with velamentous cord insertion (62%) and low-lying placenta (60%) the most prevalent. There were no perinatal deaths in women diagnosed prenatally. For the five women with vasa previa not diagnosed prenatally, there were two perinatal deaths with a case fatality rate of 40%. One woman had an antepartum stillbirth and delivered vaginally and the other four women had cesarean deliveries categorized as urgent threat to the life of a fetus with one neonatal death. The overall perinatal case fatality rate was 3.1% (95% CI 0.8-10.5). Two thirds (68%) of the 65 neonates were preterm and 29% were low birth weight. CONCLUSION: The outcomes for neonates in which vasa previa was not diagnosed prenatally were inferior with higher rates of perinatal morbidity and mortality. Our study shows a high rate of prenatal diagnosis of vasa previa in Australia and associated good outcomes.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sullivan EA, Javid N, Duncombe G, et al. Vasa Previa Diagnosis, Clinical Practice, and Outcomes in Australia. Obstet Gynecol. 2017. PMID: 28796681. doi:10.1097/AOG.0000000000002198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。